Home > Lectures > History: From Bayer to Affymax

History: From Bayer to Affymax

By Gordon Ringold - Stanford
get flash player

Lecture Description

Ringold talks about the idea behind and the history of combinatorial chemistry to accelerate the process of drug discovery. He then talks about a technology that was invented for a different purpose but was eventually applied to the specific problem of broadly monitoring the expression of gene sequences giving birth to Affymetrix.

Course Index

  1. What is an Entrepreneur?
  2. Importance of Passion
  3. Being an Entrepreneur in Industry vs. Education: Team vs. Individual
  4. Types of Company in Biotech
  5. History: From Bayer to Affymax
  6. Biotech: Collaboration vs. Competition in Developing Affymax
  7. Pharmaceutical Companies: Challenges in Developing New Therapeutic Products
  8. Funding Challenges in Today's Market
  9. History of Maxygen
  10. History of Surromed
  11. Biggest Pharmaceutical Products in Industry Today
  12. How to Operate in a Downturn Economy
  13. When and How are Patents Important?
  14. Change the Business Plan in Response to a Changing Environment